VanEck Morningstar Wide Moat ETF

VanEck ETF Trust · Series S000036713 · 1 share classes

Equity fund · 100% stocks
One fund, 1 share classes:MOAT
$11.62B NAV
58 positions · as of 2026-03-31 · filed 2026-05-28
data updated 2026-08-17

Fund profile

As filed in the prospectus · 2026 Q1

VanEck Morningstar Wide Moat ETF (the Fund) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Morningstar Wide Moat Focus Index SM (the Morningstar Wide Moat Focus Index or the Index).

Strategy · summarised

The fund tracks the Morningstar Wide Moat Focus Index using a passive replication approach, holding securities of companies Morningstar identifies as having sustainable competitive advantages and that trade at attractive valuations relative to Morningstar's fair-value estimates. The index selects from a broad U.S. market universe and currently holds 54 securities across multiple sectors. Because the fund's weighting follows index constituents' market capitalizations, concentration in a small number of issuers may increase as relative market values shift.

Expenses
0.46%one share class
Share classExpense ratio
MOAT0.46%

Portfolio turnover 55.00% · as of 2026 Q1

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q1

99.97%
of net assets
Stocks99.86%
Cash & short-term0.10%

Latest quarter

What changed since the fund's previous filing

2026Q1 vs 2025Q4: 7 new4 exited

New: BX, PANW, DDOG, VEEV, AVGO, CSGP, FICO

Exited: MRK, AMGN, JKHY, DE

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026

1-year
3-year
5-year
Volatility
Worst 3-yr fall
Cumulative return· Apr 2023 – Feb 2026

Mar 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
Bristol-Myers Squibb CoBMY2.90%$337.21M
Mondelez International IncMDLZ2.74%$318.59M
Constellation Brands IncSTZ2.74%$318.31M
Kenvue IncKVUE2.67%$309.77M
Airbnb IncABNB2.64%$306.66M
Zoetis IncZTS2.62%$304.80M
Brown-Forman CorpBF/B2.62%$303.95M
Zimmer Biomet Holdings IncZBH2.62%$303.86M
Fortinet IncFTNT2.61%$303.69M
The Clorox CoCLX2.61%$303.66M
Showing 10 of 58Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-03-31 — not a live quote, and not what the fund paid.

Top 10 positions are 26.78% of net assets, top 25 60.43%, across 58 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free